Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xeris Biopharma Holdings (XERS) Interest & Investment Income: 2020-2025

Historic Interest & Investment Income for Xeris Biopharma Holdings (XERS) over the last 5 years, with Sep 2025 value amounting to $1.2 million.

  • Xeris Biopharma Holdings' Interest & Investment Income fell 3.26% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year decrease of 24.05%. This contributed to the annual value of $5.3 million for FY2024, which is 12.00% up from last year.
  • According to the latest figures from Q3 2025, Xeris Biopharma Holdings' Interest & Investment Income is $1.2 million, which was up 22.15% from $948,000 recorded in Q2 2025.
  • Xeris Biopharma Holdings' 5-year Interest & Investment Income high stood at $1.9 million for Q1 2024, and its period low was $66,000 during Q3 2021.
  • Over the past 3 years, Xeris Biopharma Holdings' median Interest & Investment Income value was $1.2 million (recorded in 2025), while the average stood at $1.2 million.
  • Per our database at Business Quant, Xeris Biopharma Holdings' Interest & Investment Income plummeted by 96.54% in 2021 and then soared by 2,532.86% in 2022.
  • Over the past 5 years, Xeris Biopharma Holdings' Interest & Investment Income (Quarterly) stood at $70,000 in 2021, then skyrocketed by 2,532.86% to $1.8 million in 2022, then slumped by 39.93% to $1.1 million in 2023, then decreased by 17.80% to $910,000 in 2024, then fell by 3.26% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $948,000 for Q2 2025, and $1.2 million during Q1 2025.